Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#168 most reported symptom for this vaccine
Hypotension has been reported 29 times in association with RSV (Arexvy) vaccination in VAERS. This represents 0.3% of all 9,330 reports for this vaccine.
Among these reports, 4 mentioned death (13.79%) and 4 involved hospitalization (13.8%).
Hypotension is the #168 most frequently reported symptom for RSV (Arexvy) out of 947 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 29 reports of Hypotension after RSV (Arexvy) vaccination may seem alarming, but context is critical.
The 13.79% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.